Clopidogrel 75mg
Clopidogrel 75mg is a pharmaceutical drug with 21 clinical trials. Currently 2 active trials ongoing. Historical success rate of 87.5%.
Success Metrics
Based on 14 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
2
Mid Stage
9
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
87.5%
14 of 16 finished
12.5%
2 ended early
2
trials recruiting
21
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Comparison of the Effect of Medication Therapy in Alleviating Migraine With Patent Foramen Ovale
Optimal Duration of Dual Antiplatelet Therapy After Stent-assisted Coiling
Combining Aspirin With Cilostazol or Clopidogrel in Minor Stroke or TIA
Ticagrelor Compared to Clopidogrel in Acute Coronary Syndromes
Replication of the PLATO Antiplatelet Trial in Healthcare Claims Data
Clinical Trials (21)
Comparison of the Effect of Medication Therapy in Alleviating Migraine With Patent Foramen Ovale
Optimal Duration of Dual Antiplatelet Therapy After Stent-assisted Coiling
Combining Aspirin With Cilostazol or Clopidogrel in Minor Stroke or TIA
Ticagrelor Compared to Clopidogrel in Acute Coronary Syndromes
Replication of the PLATO Antiplatelet Trial in Healthcare Claims Data
Replication of the TRITON-TIMI Antiplatelet Trial in Healthcare Claims Data
Low-dose NOAC Versus GDMT After LAAO
Preventing Cardiac Complication of COVID-19 Disease With Early Acute Coronary Syndrome Therapy: A Randomised Controlled Trial.
Chronic Kidney Disease (CKD) Platelet Study
Antiplatelet vs R-tPA for Acute Mild Ischemic Stroke
Ticagrelor and Clopidogrel on Platelet Effects in Chinese Patients With Stable Coronary Artery Disease
Efficacy and Safety of Apixaban in Reducing Restenosis and Limb Loss in PAD Patients.
Comparison of CABG Related Bleeding Complications in Patients Treated With Ticagrelor or Clopidogrel
Effect of Tegoprazan or RAPA113 on Pharmacodynamics/Pharmacokinetics of Clopidogrel in Healthy Male Volunteers
The Efficacy, Safety and Pharmacokinetic of Antiplatelet Therapy for Vicagrel
Pharmacokinetics and Pharmacodynamics of Vicagrel in Healthy Adult Subjects of Different CYP2C19
LOwer Maintenance Dose TICagrelor in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention
A Novel Strategy For Personalized Long-Term Dual Antiplatelet Therapy (RAPID EXTEND PILOT STUDY)
Method of Clopidogrel Pre-treatment Undergoing Conventional Coronary Angiogram in Angina Patients
The Long Term Effect of Low Dose Aspirin on Uric Acid in Chinese Patients With Coronary Artery Disease(AURORA)
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 21